DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» SLAMF7
SLAMF7
Genetic and Genomic Analysis of Hyperlipidemia, Obesity and Diabetes Using (C57BL/6J × TALLYHO/Jngj) F2 Mice
Supplementary Table 1: Adhesion Genes Data Set
Datasheet: MCA4645FT Product Details
Restoring Natural Killer Cell Immunity Against Multiple Myeloma in the Era of New Drugs
Genetic and Functional Approaches to Understanding Autoimmune and Inflammatory Pathologies
Single-Cell Transcriptomes Reveal a Complex Cellular Landscape in the Middle Ear and Differential Capacities for Acute Response to Infection
Clinical Applications of Newly Approved Drugs
Developmental Timing of Mutations Revealed by Whole-Genome Sequencing of Twins with Acute Lymphoblastic Leukemia
PP1-Associated Signaling and − B/AP-1 Κ Inhibition of NF- Tolerance
SLAMF7 and IL-6R Define Distinct Cytotoxic Versus Helper Memory CD8+ T Cells
Targeted Therapies for Multiple Myeloma
Antibody-Drug Conjugate Targeting CD46 Eliminates Multiple Myeloma Cells
Gene Expression Derived from Alternative Promoters Improves Prognostic Stratification in Multiple Myeloma
Single-Cell Transcriptome Analysis Reveals Mesenchymal Stem Cells In
The Association Between Periodontitis and Human Colorectal Cancer: Genetic and Pathogenic Linkage
Datasheet CST 98611
Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma
WO 2019/094983 Al 16 May 2019 (16.05.2019) W 1P O PCT
Top View
Review Article CS1 (SLAMF7, CD319) Is an Effective Immunotherapeutic Target for Multiple Myeloma
Clinical Potential of SLAMF7 Antibodies – Focus on Elotuzumab in Multiple Myeloma
Mediterranean Journal Od Hematology and Infectious Diseases
Signaling Regulation of Inkt Cell Development and Function
SLAMF7 Engagement Super-Activates Macrophages in Acute and Chronic
Multiple Myeloma
Datasheet: MCA4645A647T Product Details
Monoclonal Antibodies